Literature DB >> 16157083

Microalbuminuria and C-reactive protein: similar messengers of cardiovascular risk?

Stephan J L Bakker1, Ron T Gansevoort, Erik M Stuveling, Rijk O B Gans, Dick de Zeeuw.   

Abstract

C-reactive protein (CRP) and urinary albumin excretion are both determinants of cardiovascular risk. The first is closely related to systemic and vascular low-grade inflammation, the latter is considered to be a marker of endothelial dysfunction. Because of these properties, one might presume them to be closely interrelated. In this article, we review the available evidence concerning the relationships of CRP and urinary albumin excretion, with each other and with other cardiovascular risk markers and factors. Should they be considered as dependent or independent risk markers, and which risk markers might be present in the cardiovascular risk estimation formula of the near future? The reasons that this formula might or should include CRP and urinary albumin excretion, rather than diabetes mellitus and the metabolic syndrome, are discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16157083     DOI: 10.1007/s11906-005-0075-3

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  58 in total

1.  Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study.

Authors:  M A Albert; E Danielson; N Rifai; P M Ridker
Journal:  JAMA       Date:  2001-07-04       Impact factor: 56.272

Review 2.  Clinical application of C-reactive protein for cardiovascular disease detection and prevention.

Authors:  Paul M Ridker
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

Review 3.  The effect of weight loss on a stable biomarker of inflammation, C-reactive protein.

Authors:  Marion Dietrich; Ishwarlal Jialal
Journal:  Nutr Rev       Date:  2005-01       Impact factor: 7.110

4.  Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events.

Authors:  P M Ridker; N Rifai; M Clearfield; J R Downs; S E Weis; J S Miles; A M Gotto
Journal:  N Engl J Med       Date:  2001-06-28       Impact factor: 91.245

Review 5.  Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.

Authors:  F E Harrell; K L Lee; D B Mark
Journal:  Stat Med       Date:  1996-02-28       Impact factor: 2.373

6.  Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: a placebo-controlled study using a highly sensitive C-reactive protein assay.

Authors:  M Feldman; I Jialal; S Devaraj; B Cryer
Journal:  J Am Coll Cardiol       Date:  2001-06-15       Impact factor: 24.094

7.  Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

Authors:  H C Gerstein; J F Mann; Q Yi; B Zinman; S F Dinneen; B Hoogwerf; J P Hallé; J Young; A Rashkow; C Joyce; S Nawaz; S Yusuf
Journal:  JAMA       Date:  2001-07-25       Impact factor: 56.272

8.  Association between C-reactive protein and features of the metabolic syndrome: a population-based study.

Authors:  M Fröhlich; A Imhof; G Berg; W L Hutchinson; M B Pepys; H Boeing; R Muche; H Brenner; W Koenig
Journal:  Diabetes Care       Date:  2000-12       Impact factor: 19.112

9.  Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria.

Authors:  Folkert W Asselbergs; Gilles F H Diercks; Hans L Hillege; Ad J van Boven; Wilbert M T Janssen; Adriaan A Voors; Dick de Zeeuw; Paul E de Jong; Dirk J van Veldhuisen; Wiek H van Gilst
Journal:  Circulation       Date:  2004-10-18       Impact factor: 29.690

10.  C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.

Authors:  John Danesh; Jeremy G Wheeler; Gideon M Hirschfield; Shinichi Eda; Gudny Eiriksdottir; Ann Rumley; Gordon D O Lowe; Mark B Pepys; Vilmundur Gudnason
Journal:  N Engl J Med       Date:  2004-04-01       Impact factor: 91.245

View more
  10 in total

Review 1.  The glycocalyx--linking albuminuria with renal and cardiovascular disease.

Authors:  Ton J Rabelink; Dick de Zeeuw
Journal:  Nat Rev Nephrol       Date:  2015-10-13       Impact factor: 28.314

2.  The transcription levels of ABCA1, ABCG1 and SR-BI are negatively associated with plasma CRP in Chinese populations with various risk factors for atherosclerosis.

Authors:  Chengjiang Li; Renyong Guo; Juanya Lou; Huali Zhou
Journal:  Inflammation       Date:  2012-10       Impact factor: 4.092

3.  Association of low-grade albuminuria with adverse cardiac mechanics: findings from the hypertension genetic epidemiology network (HyperGEN) study.

Authors:  Daniel H Katz; Senthil Selvaraj; Frank G Aguilar; Eva E Martinez; Lauren Beussink; Kwang-Youn A Kim; Jie Peng; Jin Sha; Marguerite R Irvin; John H Eckfeldt; Stephen T Turner; Barry I Freedman; Donna K Arnett; Sanjiv J Shah
Journal:  Circulation       Date:  2013-09-27       Impact factor: 29.690

Review 4.  Development of microalbuminuria in essential hypertension.

Authors:  Josep Redon; Jose M Pascual
Journal:  Curr Hypertens Rep       Date:  2006-05       Impact factor: 5.369

Review 5.  Statin therapy in renal disease: harmful or protective?

Authors:  Peter A McCullough; Leslie R Rocher
Journal:  Curr Atheroscler Rep       Date:  2007-01       Impact factor: 5.113

6.  Predictors of urinary albumin excretion in women with polycystic ovary syndrome.

Authors:  Antoni J Duleba; Ibrahim M Ahmed
Journal:  Fertil Steril       Date:  2009-02-12       Impact factor: 7.329

7.  Effect of zinc supplementation on microalbuminuria in patients with type 2 diabetes: a double blind, randomized, placebo-controlled, cross-over trial.

Authors:  Mahmoud Parham; Massoud Amini; Ashraf Aminorroaya; Esfandiar Heidarian
Journal:  Rev Diabet Stud       Date:  2008-08-10

8.  Statin therapy in renal disease: harmful or protective?

Authors:  Peter A McCullough; Leslie R Rocher
Journal:  Curr Diab Rep       Date:  2007-12       Impact factor: 4.810

9.  The Effects of Urinary Albumin and Hypertension on All-Cause and Cardiovascular Disease Mortality in Korea.

Authors:  Mi Hae Seo; Jong-Young Lee; Seungho Ryu; Yu Sam Won; Ki Chul Sung
Journal:  Am J Hypertens       Date:  2017-08-01       Impact factor: 2.689

10.  Relationship between lactate dehydrogenase and albuminuria in Chinese hypertensive patients.

Authors:  Xiaoqi Cai; Tingjun Wang; Chaoyi Ye; Guoyan Xu; Liangdi Xie
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-12-07       Impact factor: 3.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.